Health in Bhutan 989 indicators covering health for Bhutan. IndicatorLatest Year10-yr change Rank Estimate of current cigarette smoking prevalence (%) 5.3% 2030 down 17.2% 139th Tb patients tested positive for hiv 3 2021 — 134th Number of children aged 6-59 months with anaemia 28.42 2019 down 23.9% 149th Prevalence of anaemia in children aged 6-59 months 44.7% 2019 down 18.7% 51st Number of deaths attributed to non-communicable diseases, by type of 499.67 2019 up 36.2% 165th Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 down 66.7% 101st Mean hemoglobin level of children aged 6-59 months 111 2019 up 3.7% 136th Estimated number of MDR/RR-TB incident cases 180 2024 down 35.7% 80th Mortality caused by road traffic injury 16.2 per 100,000 population 2019 up 19.1% 84th Mortality caused by road traffic injury, female 9.5 per 100,000 female population 2019 up 15.9% 71st Mortality caused by road traffic injury, male 22.1 per 100,000 male population 2019 up 20.1% 96th Ipv vaccine coverage 99 2024 up 130.2% 1st Tb patients living with hiv receiving art 3 2021 — 117th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 unchanged 1st Hospital beds 21.62 2023 up 22.8% 88th Treatment success rate for patients treated for MDR-TB 91.0% 2022 down 9.0% 21st New leprosy case detection rate per 1 000 000 population 21.48 2024 up 2.8% 26th Treatment success rate: HIV-positive TB cases 100 2023 up 11.1% 1st Prevalence of wasting, weight for height 5.1% 2023 down 13.6% 40th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 97.0% 2025 — 29th International Health Regulations core capacity scores, SPAR version 60 2025 — 64th Prevalence of underweight, weight for age 8.7% 2023 down 31.5% 55th Leprosy registered prevalence rate per 1 000 000 population 22.74 2024 down 3.3% 30th Leprosy - Number of new leprosy cases among children 1 2024 unchanged 59th Leprosy - Number of cases registered for treatment 18 2024 unchanged 76th New leprosy child case detection rate (less than 15 years of age) per 6.04 2024 up 21.5% 20th Ipv1 number unvaccinated 391.96 2023 down 94.4% 161st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 19.6% 2024 down 13.7% 75th Number of female leprosy new cases 0 2024 — 102nd Estimated number of malaria deaths 0 2024 — 66th Estimated number of malaria cases 0 2024 down 100.0% 82nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 down 100.0% 155th Number of prevalent tuberculosis cases 1,500 2014 down 55.9% 120th Estimated malaria incidence 0 2024 down 100.0% 82nd Estimated malaria mortality rate 0 2024 — 66th Number of new G2D leprosy cases 0 2024 down 100.0% 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 down 100.0% 86th Proportion of total government spending on essential services, health 10.8% 2020 up 38.4% 59th Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 20 2023 unchanged 5th Number of deaths from malaria who 0 2024 — 66th Death rate from malaria 0 2024 — 66th Incidence of malaria 0 2024 down 100.0% 79th Share of one year olds who received the final dose of pneumococcal vac 98 2024 up 276.9% 6th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 98 2024 up 276.9% 6th Death rate from poisonings 0.1 2021 unchanged 158th Mortality rate attributed to cardiovascular disease, cancer, diabetes 15.9 % 2021 down 11.7% 104th Mortality rate attributed to unintentional poisonings, by sex 0.1 per 100,000 people 2021 unchanged 143rd Suicide mortality rate, by sex 4.9 per 100,000 people 2021 down 5.8% 116th Prevalence of stunting, height for age 17.9% 2023 down 46.6% 51st Japanese encephalitis - number of reported cases 6 2025 up 20.0% 13th Malaria cases reported 0 2024 down 100.0% 81st Deaths and missing persons due to natural disasters 3.66 2019 down 99.2% 40th Mean systolic blood pressure 123.2 2009 down 0.5% 127th Mean fasting blood glucose (mmol/l) 5.8 2009 up 5.5% 15th Number of pregnant women living with HIV who received antiretrovirals 5 2025 up 66.7% 104th Hiv expenditure 242,153 2024 — 93rd Number of new leprosy cases with G2D among children 0 2024 — 35th Neonates protected at birth against neonatal tetanus (PAB) 95.0% 2022 up 6.7% 35th ← Previous Page 15 of 17 Next →